This exaggerated meal-stimulated GLP-1 release likely contributes to improved satiety and metabolic benefits
USA 103, 1387213877 (2006)
Researchers reported in BMJ Medicine on a retrospective observational study of more than 130,000 U.S
It should only be considered after reviewing potential benefits, risks, side effects, costs, and the patients medical history
Because its designed with GLP-1 users in mind, it contains nutrients that may be difficult to get enough of with a significantly reduced appetite
Heres how we do it: Baseline skin and facial analysis: We assess hydration, elasticity, and fat distribution before treatment starts